Tarsus Pharmaceuticals, Inc. · 9 hours ago
Intern, Procurement
Irvine, California, United States
Internship
Hybrid
Intern
$26/hr - $45/hrTarsus Pharmaceuticals is a growing biopharmaceutical organization seeking a Procurement Intern to support their Procurement and Supply Chain team. The role involves hands-on exposure to procurement, supplier management, and supply chain processes, while working cross-functionally with various teams to enhance operational efficiency.
BiopharmaBiotechnologyLife Science
Responsibilities
Support procurement and strategic sourcing activities through data collection, supplier comparisons, and analysis
Assist with spend analysis, reporting, and dashboard preparation
Help organize supplier documentation, contracts, and compliance materials
Support supplier onboarding and performance tracking efforts
Assist with supply chain planning, inventory, or operational analyses as needed
Prepare presentations and summaries for internal stakeholders and leadership
Participate in process improvement initiatives within procurement
Qualification
Required
Currently enrolled in an undergraduate or graduate program in Supply Chain Management, Business, Finance, Operations, Engineering, or a related field
Strong interest in procurement, strategic sourcing, and/or supply chain management
Strong analytical, organizational, and communication skills
Ability to manage multiple tasks and work effectively in a fast-paced environment
Proficiency in Microsoft Excel, PowerPoint, and Word
Preferred
Familiarity with ERP or procurement systems is a plus
Benefits
Hybrid work environment
Lunch and learns
Development opportunities
Offsite volunteering
Company-wide social events
Company
Tarsus Pharmaceuticals, Inc.
Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care.
Founded in 2017
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$710.6MKey Investors
Pharmakon AdvisorsVivo Capital
2025-03-12Post Ipo Equity· $125M
2024-04-19Post Ipo Debt· $75M
2024-02-29Post Ipo Equity· $100M
Leadership Team
Jeffrey Farrow
Chief Financial Officer and Chief Strategy Officer
Bobak Azamian
Chairman
Recent News
Tarsus Pharmaceuticals, Inc
2025-11-06
Tarsus Pharmaceuticals, Inc
2025-11-05
2025-11-05
Company data provided by crunchbase